Cargando…
Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents
BACKGROUND: The simian malaria parasite Plasmodium knowlesi is now a well-recognized pathogen of humans in South-East Asia. Clinical infections appear adequately treated with existing drug regimens, but the evidence base for this practice remains weak. The availability of P. knowlesi cultures adapte...
Autores principales: | van Schalkwyk, Donelly A, Moon, Robert W, Blasco, Benjamin, Sutherland, Colin J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890772/ https://www.ncbi.nlm.nih.gov/pubmed/28961865 http://dx.doi.org/10.1093/jac/dkx279 |
Ejemplares similares
-
Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum
por: van Schalkwyk, Donelly A., et al.
Publicado: (2019) -
Ex vivo susceptibility to new antimalarial agents differs among human-infecting Plasmodium species
por: van Schalkwyk, Donelly A., et al.
Publicado: (2021) -
Cation ATPase (ATP4) Orthologue Replacement in the Malaria Parasite Plasmodium knowlesi Reveals Species-Specific Responses to ATP4-Targeting Drugs
por: Mohring, Franziska, et al.
Publicado: (2022) -
Diagnostic accuracy and limit of detection of ten malaria parasite lactate dehydrogenase-based rapid tests for Plasmodium knowlesi and P. falciparum
por: Tan, Angelica F., et al.
Publicado: (2022) -
Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline
por: Kreutzfeld, Oriana, et al.
Publicado: (2023)